BioNexus Gene Lab Corp. (BGLC)
$1.29+3.20%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 2.21
- P/E (TTM)
- -0.98
- Short % float
- 0.78%
- Days to cover
- 1.5
- SI change
- -22.4%
- 1W
- +1.57%
- 1M
- -12.84%
- vs SPY 1W
- +0.41%
- vs SPY 1M
- -15.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 4
- GROWTH
- 32
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.7%
REV YoY-
ROE-32.9%
EPS YoY-
ROA-29.5%
GROSS12
OP-83
NET-82
[VALUATION]
P/E TTM-0.98
P/E FWD-
SECTOR PE18.05
INDUSTRY PE52.50
P/B0.39
P/FCF-
EV/EBITDA-0.81
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.55
ALTMAN Z-
CURR RATIO6.08
ND/EBITDA-
BETA2.21